Qianhai Health Holdings Limited provided unaudited consolidated earnings guidance for the six months ended June 30, 2021. For the six months, the Group expects to incur a loss attributable to shareholders of the Company for the six months ended 30 June 2021 as compared to a profit attributable to shareholders of the Company for the six months ended 30 June 2020 of approximately HKD 6.9 million. The turnaround from profit to loss for the six months ended 30 June 2021 is mainly attributable to: (i) the decrease in the business activities of Group in both health-care business and electronic component products business owing to the impact of the prolonged outbreak of the novel coronavirus pandemic, thereby leading to a decrease in revenue by approximately 50% as compared to that of the corresponding period in 2020; and (ii) the increase of share of loss of a jointly controlled entity, which engaged in joint development of the a land parcel in China. Except for the provision for impairment loss under the expected credit loss model on the trade receivables that the Group required more time and information to work on the estimation, the Group is expected to record a net loss of not less than HKD10.6 million for the six months ended 30 June 2021.